脾功能亢进

TIPS联合PSE治疗肝硬化门静脉高压及脾功能亢进的临床疗效研究

The Study on Clinic Effects of TIPS Combines with PSE in the Treatment of Portal Hypertension and Hypersplenism

结论：TACE联合PSE是治疗原发性肝癌并发肝硬化、门脉高压和脾功能亢进安全、有效的方法。

Conclusion : TACE combined with PSE is a safe and effective method to treat HCC with liver cirrhosis , portal hypertension and hypersplenism .

方法87例脾功能亢进患者均经B超、CT、实验室检查、造影等确诊，用介入方法行部分脾动脉栓塞术。

Method 87 cases of hypersplenia were diagnosed by B-type ultrasound , CT , the laboratory examination and visualization .

门静脉高压症脾功能亢进患者脾巨噬细胞Toll样受体4的表达及其意义

Expression and significance of Toll-like receptor 4 of splenic macrophage in patients with hypersplenism due to portal hypertension

脾亢组动物有脾功能亢进的表现，肝硬化程度较重，最终成癌率较对照组显著增加（P＜0.05）。

The degree of liver cirrhosis of the animals in the group with hypersplenism was more serious than the animals in the other two groups , and the incidence of HCC was higher than the other two groups ( P0.05 ) .

方法从1996年4月至1999年7月，进行了13例LS，其中12例为原发性或继发性脾功能亢进，1例为脾囊肿。

Methods Thirteen patients underwent LS between April 1996 and July 1999 , there were 12 cases of secondary hypersplenism and one case of splenic cyst .

方法39例肝硬化合并脾肿大、脾功能亢进患者，11例使用钢圈栓塞，15例使用明胶海绵栓塞，13例使用PVA颗粒栓塞。

Methods Thirty nine patients of cirrhosis with hypersplenism and hypersplenotrophy , 11 of them were treated with steel coils , 15 with gelfoam , 13 with the PVA .

目的了解充血性脾肿大伴脾功能亢进（脾亢）患者血小板相关抗体（PAIgG）水平及不同脾切除术后的改变，探索脾肿大、血小板、PAIgG之间的关系。

Objective To defect the level of platelet antibody IgG ( PA IgG ) in patients with congestive splenomegaly and hypersplenism and the change of PA IgG level after splenectomy and subtotal splenectomy .

目的研究门脉高压，脾功能亢进病人部分脾栓塞（PSE）前后门脉压力改变，以期得到PSE对门脉压力改变的影响。

Objective To research the changes of pressure of portal vein and its branches before and after PSE in patients with portal hypertension .

结论：栓塞程度控制在50%~70%的PSE能有效治疗肝硬化脾功能亢进。

Conclusions : The embolization of the degree ranging from 50 % to 70 % may alleviate hypersplenism in patients with liver cirrhosis .

方法：对76例门静脉高压症合并食管曲张静脉出血和脾功能亢进病人实施EVL联合PSE治疗。

Methods : EVL-PSE was performed in a group of 76 patients with esophageal variceal bleeding and hypersplenism due to portal hypertension .

目的探讨不同栓塞材料在肝硬化合并脾功能亢进部分性脾栓塞术（PSE）中的临床应用。

Objective To evaluate the clinical efficiency of partial splenic embolization ( PSE ) using different embolic material for patients with hypersplenism in cirrhosis of liver .

结果表明，SBP的危险因素与患者住院时间长短、血浆蛋白水平、脾功能亢进以及是否合并肝性脑病和消化道出血等因素密切相关。

Conclusion The risk factors for SBP in patients with liver Cirrhosis may be associated with patients duration of hospitalization , low plasma albumin content , hypersplenism , hepatic encephalopathy , and hemorrhage of digestive tract .

方法：20例肝硬化脾功能亢进患者，使用明胶海绵颗粒（1mm×1mm×1mm）栓塞，栓塞程度50%~70%。

Methods : Twenty patients with liver cirrhosis and hypersplenism were treated with gelfoam ( 1 mm × 1 mm × 1 mm ) . The embolization degree ranged from 50 % to 70 % .

方法应用海藻酸钠微球（KMG）和微导管系统对常规导管不能超选择的18例脾功能亢进患者行部分性脾栓塞术。

Methods PSE by using KMG particles and by using microcatheter in18 patients with hypersplenism , who were unable to adopt the conventional catheter .

目的：门静脉高压症（PHT）合并脾功能亢进（脾亢）时，患者全身免疫系统紊乱。目前对肿大的脾脏是否仍旧具有免疫功能及其在体内的调节机制尚未达成共识。

Objectives : Portal hypertension ( PHT ) merger splenic hyperfunction , the immune function of patients in a state of disorder , at present the enlargement of the spleen immune function evaluation yet to come more united and the control mechanism is unclear .

结论EVL联合PSE治疗肝硬变食管静脉曲张出血并脾功能亢进安全有效，近期、远期都有较高的食管静脉曲张根治率及较低的再出血率，远期疗效优于EVL，值得推广。

Conclusion The treatment with EVL combined with PSE in patients with liver cirrhosis complicated with esophageal varices bleeding and hypersplenism is safe and effective , which has higher short-term and long-term eradication rate and lower rebleeding rate , and long-term therapeutic efficacy is superior to EVL , worth spreading .

脾功能亢进常继发于肝硬化所致的门静脉高压症，临床上对于脾功能亢进的研究相对比较滞后，进展不大。

Hypersplenism secondary to liver cirrhosis usually caused by portal hypertension .

肝硬化门脉高压继发脾功能亢进的介入治疗

The Interventional Therapy for Hypersplenism Caused by Liver Cirrhosis and Portal Hypertension

射频消融治疗脾功能亢进症对机体免疫功能影响的研究

Influences of Radiofrequency Ablation Treatment for Hypersplenism on Immune Function

腹腔镜下射频消融治疗门脉高压性脾功能亢进的临床研究

Clinical study of laparoscopic radiofrequency ablation for hypersplenism caused by portal hypertention

快速建立继发性脾功能亢进的犬动物模型

Rapid establishment of a canine model of secondary hypersplenism

丝线加明胶海绵脾脏栓塞治疗脾功能亢进。

Splenic embolization in treatment of hypersplenism using both silk threads and gelfoam .

脾功能亢进症部分性脾动脉栓塞治疗术后并发症的原因分析及护理对策

Causes and the Corresponding Nursing Measures to Complications of Partial Splenic Embolization for Hypersplenia

肝硬化门静脉高压性脾肿大并发脾功能亢进的特点及临床意义

Characteristics and clinical significance of hypersplenism secondary to splenomegaly caused by cirrhotic portal hypertension

原位肝移植术后脾功能亢进的恢复

Change in hypersplenism after orthotopic liver transplantation

文摘：对21例门静脉高压脾功能亢进患者进行了部分性脾栓塞治疗。

Abstract : twenty-one cases of hypersplenism with portal hypertension were treated with partial splenic embolization .

充血性脾大伴脾功能亢进患者不同脾切除术前后血小板相关抗体的变化

Changes of platelet antibody IgG level in patients with congestive splenomegaly and hypersplenism after different splenic operations

目前的研究主要集中在门静脉高压脾功能亢进时，病理的脾脏应该保留还是切除的问题。

The current study of hypersplenism mainly focused on the pathological spleen should be retained or should be removed .

健脾疏肝汤联合肝脾双栓治疗原发性肝癌合并脾功能亢进临床研究

The clinical study of interventional therapy combining with Jianpi Shugan decoction for treatment of primary hepatic carcinoma with spleen hyperfunction